FIELD: medicine.
SUBSTANCE: invention presents a method for evaluating a risk of developing cardiovascular complications in females suffering from the hypertensive disease by blood sampling from the patients, blood measuring for interleukin-α, receptor interleukin-1 antagonist by the immunoenzyme technique differing by determining a value equal to a relation of the receptor interleukin-1 to interleukin-1α antagonist, a leukemia blood cell inhibition factor and a CD34 cell count that is followed by diagnosing developing cardiovascular complications for the following 5 years with stating a high, medium or low risk of developing complications.
EFFECT: invention enables providing the more accurate evaluation of an individual risk of developing fatal and nonfatal cardiovascular events in the females suffering from essential arterial hypertension.
1 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DETERMINING PREDICTION OF COMPLICATIONS OF CARDIOVASCULAR DISEASES DURING EXTREME CHANGES IN CLIMATIC CONDITIONS | 2018 |
|
RU2684286C1 |
METHOD FOR DETERMINING RISK OF DEVELOPING ACUTE CEREBROVASCULAR ACCIDENT IN PATIENTS WITH ESSENTIAL ARTERIAL HYPERTENSION FOR 12 MONTHS AFTER COVID-19 | 2023 |
|
RU2826593C1 |
METHOD FOR DETERMINING THE RISK OF DEVELOPING CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH STAGE II ESSENTIAL ARTERIAL HYPERTENSION WITHIN 12 MONTHS AFTER COVID-19 | 2021 |
|
RU2767624C1 |
METHOD FOR PREDICTION OF EROSION OF VAGINAL MUCOSA AFTER SURGICAL CORRECTION OF GENITAL PROLAPSE WITH USING MESH IMPLANTS IN POSTMENOPAUSAL WOMEN | 2020 |
|
RU2737651C1 |
METHOD FOR PREDICTION OF BRONCHOPULMONARY DYSPLASIA IN NEWBORNS WITH VERY LOW OR EXTREMELY LOW BODY WEIGHT | 2012 |
|
RU2480766C1 |
METHOD FOR EARLY PREDICTION OF PNEUMONIAS IN SMALL PREMATURE NEWBORNS SUFFERING RESPIRATORY DISTRESS SYNDROME | 2011 |
|
RU2463607C1 |
METHOD FOR ASSESSING RISK OF UNFAVOURABLE CARDIOVASCULAR EVENTS IN PATIENTS WITH CLINICAL MANIFESTATIONS OF ATHEROSCLEROSIS | 2014 |
|
RU2574896C2 |
METHOD FOR PREDICTING THE LETHAL OUTCOME IN PATIENTS WITH SEVERE CoVID-19 | 2021 |
|
RU2780748C1 |
METHOD OF PREDICTION OF ASPIRIN RESISTANCE | 2015 |
|
RU2602664C1 |
METHOD OF IMMUNOTHERAPY OF PURULENT RHINOSINUSITIS | 2010 |
|
RU2457789C2 |
Authors
Dates
2014-10-10—Published
2013-10-30—Filed